NEW YORK (GenomeWeb) – Advanced Biological Laboratories announced it has granted Abbott non-exclusive rights to sell its HIV genotypic data analysis software suite.

Abbott will market ABL's data analysis software to its customers within the US, the largest market in the world for HIV genotyping for diagnostic use and in clinical trials. ABL, based in Luxembourg, is aiming to expand the presence and use of its products in the US market, CEO Chalom Sayada said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.